+499.5%
MRNA vs CGNX
+42.4%
+457.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CGNX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +2.4% | -4.6% | -2.0% |
| 7D | +5.5% | +3.0% | +2.5% | +5.8% |
| 30D | +158.7% | -11.8% | +170.6% | +162.8% |
| 3M | +182.1% | -3.6% | +185.7% | +181.0% |
| 6M | +151.8% | +17.4% | +134.4% | +143.9% |
| YTD | +393.6% | +73.7% | +319.8% | +361.7% |
| 1Y | +499.5% | +41.5% | +457.9% | +418.9% |
| All | +499.5% | +42.4% | +457.1% | +418.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CGNX.
Daily Out/Under-Performance
Portfolio return minus CGNX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CGNX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CGNX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling